Insider Transactions in Q2 2022 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Richard Makara VP, Head of Accting;Controller |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+35.57%
|
-
|
|
Jun 02
2022
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
35,628
+26.33%
|
-
|
|
Jun 02
2022
|
Harrison M Bains Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,876
+26.9%
|
-
|
|
Jun 02
2022
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
11,876
+38.37%
|
-
|
|
Jun 02
2022
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
11,876
+38.37%
|
-
|
|
Apr 04
2022
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,006
-0.99%
|
$24,072
$12.67 P/Share
|
|
Apr 01
2022
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
1,784
-1.04%
|
$19,624
$11.91 P/Share
|
|
Apr 01
2022
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,642
-2.15%
|
$18,062
$11.91 P/Share
|
|
Apr 01
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
1,642
-1.58%
|
$18,062
$11.91 P/Share
|